These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38573243)

  • 21. Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?
    Bover J; Górriz JL; Ureña-Torres P; Lloret MJ; Ruiz-García C; daSilva I; Chang P; Rodríguez M; Ballarín J
    Nefrologia; 2016; 36(6):587-596. PubMed ID: 27575927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment.
    Vachey C; Candellier A; Toutain S; Mac-Way F
    Curr Osteoporos Rep; 2024 Feb; 22(1):69-79. PubMed ID: 38195897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
    Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
    J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
    Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
    Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
    Hutcheson JD; Goettsch C
    Circ Res; 2023 Apr; 132(8):993-1012. PubMed ID: 37053279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease.
    Levy DS; Grewal R; Le TH
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F618-F623. PubMed ID: 32830534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcification of Cardiac Valves in Metabolic Bone Disease: An Updated Review of Clinical Studies.
    Carrai P; Camarri S; Pondrelli CR; Gonnelli S; Caffarelli C
    Clin Interv Aging; 2020; 15():1085-1095. PubMed ID: 32764895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health.
    Bellone F; Cinquegrani M; Nicotera R; Carullo N; Casarella A; Presta P; Andreucci M; Squadrito G; Mandraffino G; Prunestì M; Vocca C; De Sarro G; Bolignano D; Coppolino G
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of the chronic kidney disease-mineral bone disorder.
    Hruska KA; Seifert M; Sugatani T
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):303-9. PubMed ID: 26050115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease.
    Zoccali C; London G
    Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of the mechanisms in vascular calcification during chronic kidney disease.
    Voelkl J; Cejka D; Alesutan I
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):289-296. PubMed ID: 30985336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity.
    Jaminon AMG; Akbulut AC; Rapp N; Kramann R; Biessen EAL; Temmerman L; Mees B; Brandenburg V; Dzhanaev R; Jahnen-Dechent W; Floege J; Uitto J; Reutelingsperger CP; Schurgers LJ
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?
    Hildebrand S; Cunningham J
    Bone; 2021 Jan; 142():115751. PubMed ID: 33188959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future therapy.
    Pongsuwan K; Kusirisin P; Narongkiattikhun P; Chattipakorn SC; Chattipakorn N
    J Cell Physiol; 2022 Dec; 237(12):4369-4396. PubMed ID: 36183389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin K and vascular calcification.
    Lees JS; Mark PB; Witham MD
    Curr Opin Nephrol Hypertens; 2021 Jul; 30(4):430-436. PubMed ID: 33871429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.